Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Justification for type of information:
For details on endpoint-specific justification, please see read-across justification document (category approach) in the linked category of dimethylalkylamines.

Data source

Materials and methods

Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
Amines, C16-18-alkyldimethyl
EC Number:
269-915-2
EC Name:
Amines, C16-18-alkyldimethyl
Cas Number:
68390-97-6
Molecular formula:
R-N(Me)2, whereas R= C16-18-alkyl (even numbered, unbranched, saturated)
IUPAC Name:
N,N-dimethyl-C16-18-(even numbered)-alkyl-1-amines

Results and discussion

Test results
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
Exp I: at concentrations of 15.6 and 31.3 µg/mL, Exp II: at all concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid

Any other information on results incl. tables

Results presented above were obtained with the source substance C12-18 DMA.


 


Additional results for C12-18 DMA:





















































































































































































Exp.Preparation intervalTest item concentration in µg/mLPolyploid cells in %Cell numbers in % of controlMitotic indices in % of controlincl.gaps*Aberrant cells in % excl.gaps*with exchanges
Exposure period 4 hrs without S9 mix
I18 hrsSolvent control12,71001002,52,50,5
  Positive control23,1n.t100,81210,556,5
  22,956,997,53,531
  3,9469,5933,52,50
  7,82,562,784,42,520
  Exposure period 18 hrs without S9 mix
II18 hrsSolvent control12,31001001,51,50,5
  Positive control32,8n.t100,89,59,556,5
  13,1104,497,51,51,51
  23,164,2931,51,50
  3,9##3,228,384,42,82,50
Exposure period 28 hrs without S9 mix
II28 hrsSolvent control11,2100100220
  Positive control3*2,8n.t67,14949,0518
  1372,1101,92,52,50
  24,437,770,6320

*: Inclusive cells carrying exchanges


#: Evaluation of 50 metaphase plates per culture


##: Evaluation of 200 metaphase plates per culture


n.t: Not tested


P: Precipitation occurred


S: Aberration frequency statistically significant higher than corrresponding control values


1: Ethanol 0.5%(v/v)


2: EMS 900.0 µg/ml


3: EMS 500.0 µg/mL


 















































































































































Exp.Preparation intervalTest item concentration in µg/mLPolyploid cells in %Cell numbers in % of controlMitotic indices in % of controlincl.gaps*Aberrant cells in % excl.gaps*with exchanges
Exposure period 4 hrs without S9 mix
I18 hrsSolvent control13,51001001,510
  Positive control23,1n.t59,610,510,55 2
  3,92,482,4121,11,51,50,5
  7,8P3,496,9137,832,50,5
  15,6P3,362,1128,964,05 0,5
Exposure period 28 hrs with S9 mix
II28 hrsSolvent control11,710010021,50,5
  Positive control3*1,6n.t101,41211,5 s3,5
  3,92,694,7101,432,50,5
  7,8P2,8124,9106,14,540,5
  15,6P2,297,196,42,520,5
  31,3P332,283,91,510

*: Inclusive cells carrying exchanges


n.t: not tested


P: Precipitation occurred


S: Aberration frequency statistically significant higuer than corrresponding control values


1: Ethanol 0.5 % (v/v)


2: CPA 1.4 µg/mL


3: CPA 2.0 µg/mL


 









































 without S9 mixwith S9 mix
 Exp.IExp. IIExp.IExp. II
Exposure period4 hrs18 hrs28 hrs4 hrs4 hrs
Recovery14 hrs--14 hrs24 hrs
Preparation interval18 hrs18 hrs28 hrs18 hrs28 hrs

 






































































Exp.Preparation intervalExposure periodConcentration in µg/mL
    without S9 mix
I18 hrs4 hrs 23,97,8
II18 hrs18 hrs 123,9
II28 hrs28 hrs  12
    with S9 mix
I18 hrs4 hrs 3,97,8P15,6P
II28 hrs4 hrs3,97,8P15,6P31,3P

P: precipitation occurrred


 


In the absence of S9 mix, 4 hrs exposure resulted in the cell number reduction to 62.7% of control at 7.8 µg/mL. Evaluation of cytogenetic damage at the next higher concentration of 15.6µg/mL was not possible due to the observed high cytotoxicity, the cell number reduction being 3.9% of control. In the experiments with treatment periods of 18 and 28 hrs, evaluation of cytogenetic damage was performed up to the concentrations inducing a cell number reduction to 28.3 and 37.7% of control, respectively.


In the first experiment, in the presence of S9 mix, after 4 hrs exposure with 15.6µg/mL at the 18 hrs preparation interval resulted in a cell number reduction to 62.1% of control. Evaluation of cytogenetic damage at the next higher concentration of 31.3µg/mL was not possible due to the observed high cytotoxicity, the cell number reduction being 3.5% of damage was performed up to the concentration inducing cell number reduction to 32.2 of control.

Applicant's summary and conclusion

Executive summary:

The study used as source investigated the in vitro gene cytogenicity of C12-18 DMA. The study results of the source compound were considered applicable to the target compound. Justification and applicability of the read-across approach (category approach) is outlined in the read-across report in the linked category of dimethylalkylamines.